Drug Safety Project

Copy the URL for use in an RSS reader:

The drug supply chain has become increasingly complex in recent years. Today’s prescription and over-the-counter remedies originate in factories all over the world, moving into American homes through supply chains that can involve numerous processing plants, manufacturers, suppliers, brokers, packagers, and distributors. This increases the risk that substandard or counterfeit medicines could reach patients and contributes to shortages of essential medicines. Pew’s work on drug safety helps to ensure a safe, reliable pharmaceutical manufacturing and distribution system.

Our Work

View All
  • FDA Proposals for Compounded Drugs Draw Broad Support

    The U.S. Food and Drug Administration (FDA) issued three draft guidance documents in April on implementation of the Drug Quality and Security Act (DQSA), a 2013 law governing the production of compounded drugs—medications made by pharmacies instead of drug manufacturers. Read More

  • Pew Urges Senate to Protect Patient Safeguards in Compounding Law

    The Pew Charitable Trusts, together with the American Public Health Association, the Biotechnology Innovation Organization, the Generic Pharmaceutical Association, the Pharmaceutical Research and Manufacturers of America, and Trust for America’s Health, sent a letter to the chair and ranking member of the U.S. Senate Appropriations Subcommittee on Agriculture, Rural Development, Food and... Read More

  • Drug Compounding: Steps to Boost Public Safety

    Compounded drugs—medications mixed or altered by pharmacists—are a critical component of health care, but they can carry serious, yet little-known, risks to patient safety. In light of Patient Safety Awareness Week from March 13 to 19, now is a good time for the public and health care professionals to understand the facts and concerns behind drug compounding.  Read More

Media Contact

Tami Holzman

Officer, Communications